Beeline Medicines
The Medical Director, Clinical Development at Beeline Medicines will provide medical leadership for clinical trials in immunology, overseeing study design, execution, safety monitoring, data interpretation, and regulatory deliverables. The role involves collaborating with cross‑functional teams and external experts to shape development strategy for autoimmune disease therapies.
Beeline Medicines is a clinical-stage biotechnology company focused on developing and delivering category-leading precision therapies that target the drivers of immune dysfunction. The company is advancing a pipeline of therapies for autoimmune and inflammatory diseases, including its lead program afimetoran, a TLR7/8 inhibitor in late-stage clinical development for lupus. Beeline Medicines aims to define new treatment paradigms for patients living with chronic immune-mediated conditions.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Beeline Medicines.
30% above the average for this role
Medical Director, Early R&I Clinical Development
AstraZeneca
Medical Science Liaison - Immunology - Philadelphia/Baltimore
AstraZeneca
Senior Director, Translational Medicine Lead – Autoimmune
Moderna
Medical Director, Immunology Clinical Development - Rheumatology
AbbVie
Executive Medical Director - Physician -Early Clinical Development, Immunology
Eli Lilly and Company
Vice President/Senior Vice President, Clinical Development (AID)
Janux Therapeutics